89 related articles for article (PubMed ID: 9111819)
1. Effect of data normalization for age on the correlations between corneometric values and serum molecule levels in plaque-type psoriatic patients.
Carducci M; Mussi A; Bonifati C; Pietravalle M; Alemanno L; Fazio M; Ameglio F
Acta Derm Venereol; 1997 Mar; 77(2):110-4. PubMed ID: 9111819
[TBL] [Abstract][Full Text] [Related]
2. Correlation of lesional skin corneometry values with serum E-selectin levels and disease severity in patients affected by plaque-type psoriasis: recovery after effective therapy.
Carducci M; Mussi A; Bonifati C; Tomaselli R; Onorati MT; Trento E; Ameglio F
J Dermatol; 1995 Jul; 22(7):475-9. PubMed ID: 7560436
[TBL] [Abstract][Full Text] [Related]
3. Abnormal corneometric values of non-lesional plaque-type psoriatic skin.
Mussi A; Carducci M; Bonifati C; Fazio M; Ameglio F
Acta Derm Venereol; 1997 May; 77(3):237-8. PubMed ID: 9188882
[No Abstract] [Full Text] [Related]
4. Soluble E-selectin and soluble tumour necrosis factor receptor (60 kD) serum levels in patients with psoriasis.
Bonifati C; Trento E; Carducci M; Sacerdoti G; Mussi A; Fazio M; Ameglio F
Dermatology; 1995; 190(2):128-31. PubMed ID: 7537129
[TBL] [Abstract][Full Text] [Related]
5. Plasma transforming growth factor beta1 as a biomarker of psoriasis activity and treatment efficacy.
Flisiak I; Porebski P; Flisiak R; Chodynicka B
Biomarkers; 2003; 8(5):437-43. PubMed ID: 14602527
[TBL] [Abstract][Full Text] [Related]
6. Novel inflammatory markers in psoriasis vulgaris: vaspin, vascular adhesion protein-1 (VAP-1), and YKL-40.
Ataseven A; Kesli R
G Ital Dermatol Venereol; 2016 Jun; 151(3):244-50. PubMed ID: 25279492
[TBL] [Abstract][Full Text] [Related]
7. Vascular adhesion protein-1 (VAP-1) is overexpressed in psoriatic patients.
Madej A; Reich A; Orda A; Szepietowski JC
J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):72-8. PubMed ID: 17207171
[TBL] [Abstract][Full Text] [Related]
8. Effect of psoriasis activity on epidermal growth factor (EGF) and the concentration of soluble EGF receptor in serum and plaque scales.
Flisiak I; Szterling-Jaworowska M; Baran A; Rogalska-Taranta M
Clin Exp Dermatol; 2014 Jun; 39(4):461-7. PubMed ID: 24825137
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis in psoriatic skin and its modifications after administration of etanercept: videocapillaroscopic, histological and immunohistochemical evaluation.
Campanati A; Goteri G; Simonetti O; Ganzetti G; Giuliodori K; Giuliano A; Sabato S; Stramazzotti D; Gulini E; Dusi D; De Blasio S; Fabris G; Offidani A
Int J Immunopathol Pharmacol; 2009; 22(2):371-7. PubMed ID: 19505391
[TBL] [Abstract][Full Text] [Related]
10. Effect of narrow-band UVB phototherapy on soluble cell adhesion molecules in patients with psoriasis vulgaris.
Long JW; Tao J; Pi XM; Wang YY; Tu YT
J Int Med Res; 2010; 38(4):1507-12. PubMed ID: 20926025
[TBL] [Abstract][Full Text] [Related]
11. Association between psoriasis severity and transforming growth factor beta(1) and beta (2) in plasma and scales from psoriatic lesions.
Flisiak I; Chodynicka B; Porebski P; Flisiak R
Cytokine; 2002 Aug; 19(3):121-5. PubMed ID: 12242078
[TBL] [Abstract][Full Text] [Related]
12. Serum and tissue expression of transforming growth factor beta 1 in psoriasis.
Zaher H; Shaker OG; EL-Komy MH; El-Tawdi A; Fawzi M; Kadry D
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):406-9. PubMed ID: 19175705
[TBL] [Abstract][Full Text] [Related]
13. Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis.
Mussi A; Bonifati C; Carducci M; D'Agosto G; Pimpinelli F; D'Urso D; D'Auria L; Fazio M; Ameglio F
J Biol Regul Homeost Agents; 1997; 11(3):115-8. PubMed ID: 9498161
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations of transforming growth factor beta 1 in patients with psoriasis vulgaris.
Nockowski P; Szepietowski JC; Ziarkiewicz M; Baran E
Acta Dermatovenerol Croat; 2004; 12(1):2-6. PubMed ID: 15072741
[TBL] [Abstract][Full Text] [Related]
15. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis.
Debets R; Hegmans JP; Croughs P; Troost RJ; Prins JB; Benner R; Prens EP
J Immunol; 1997 Mar; 158(6):2955-63. PubMed ID: 9058835
[TBL] [Abstract][Full Text] [Related]
16. Videocapillaroscopic findings in the microcirculation of the psoriatic plaque during etanercept therapy.
Stinco G; Buligan C; Maione V; Valent F; Patrone P
Clin Exp Dermatol; 2013 Aug; 38(6):633-7. PubMed ID: 23763515
[TBL] [Abstract][Full Text] [Related]
17. Epidermal barrier and oxidative stress parameters improve during in 311 nm narrow band UVB phototherapy of plaque type psoriasis.
Darlenski R; Hristakieva E; Aydin U; Gancheva D; Gancheva T; Zheleva A; Gadjeva V; Fluhr JW
J Dermatol Sci; 2018 Jul; 91(1):28-34. PubMed ID: 29610017
[TBL] [Abstract][Full Text] [Related]
18. Serum irisin levels in patients with psoriasis.
Baran A; Myśliwiec H; Kiluk P; Świderska M; Flisiak I
J Dermatolog Treat; 2017 Jun; 28(4):304-308. PubMed ID: 27786588
[TBL] [Abstract][Full Text] [Related]
19. Prolactin level is significantly elevated in lesional skin of patients with psoriasis.
El-Khateeb EA; Zuel-Fakkar NM; Eid SM; Abdul-Wahab SE
Int J Dermatol; 2011 Jun; 50(6):693-6. PubMed ID: 21595663
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine, vitamin B12 and folic acid levels in psoriatic patients and correlation with disease severity.
Brazzelli V; Grasso V; Fornara L; Moggio E; Gamba G; Villani S; Borroni G
Int J Immunopathol Pharmacol; 2010; 23(3):911-6. PubMed ID: 20943063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
